Aug. 28, 2013
/PRNewswire/ -- The Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected
Marschall S. Runge
, M.D., Ph.D., as a new member, effective
September 1, 2013
. Dr. Runge, 59, is the Executive Dean for the School of Medicine at the
University of North Carolina at Chapel Hill
). As a member of Lilly's board, Dr. Runge will serve on the Science and Technology Committee and the Public Policy and Compliance Committee.
"I am very pleased to welcome
to the Lilly board," said
, Ph.D., Lilly chairman, president and chief executive officer. "Dr. Runge brings to the Lilly board a broad background in health care, with extensive experience as a practicing physician, clinical researcher, and dean of a major academic medical institution. His appreciation of the importance of scientific research, coupled with his first-hand experience in patient care, will help Lilly deliver on its commitment to discover and develop innovative medicines that make a difference for patients in need."
In his role as Executive Dean for the UNC School of Medicine, Dr. Runge provides overall academic and clinical leadership for the School of Medicine and the UNC Health Care System. In addition to being the Chair of the Department of Medicine, Dr. Runge is also Principal Investigator and Director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at
, where he has financial, human resource and strategic oversight responsibilities for the program. The NC TraCS Institute is one of 60 medical research institutions working together as part of a national consortium to improve the way biomedical research is conducted across the country and to reduce the time it takes for laboratory discoveries to become new treatments for patients.
An honors graduate of
with a B.A. in Biology and a Ph.D. in molecular biology, Dr. Runge earned his M.D. from the
Johns Hopkins School of Medicine
, where he was an intern and resident in internal medicine. He then completed a cardiology fellowship at
General Hospital and was a faculty member there prior to moving to
as an Associate Professor of Medicine in 1989. Before joining the
faculty in 2000, Dr. Runge held the John Sealy Distinguished Centennial Chair in Internal Medicine and was Director of the Division of Cardiology and the Sealy Center for Molecular Cardiology at the
University of Texas
Medical Branch at
In addition to serving as a member of the Experimental Cardiovascular Sciences Study Section of the National Institutes of Health, Dr. Runge also has published over 150 peer-reviewed manuscripts and is a renowned leader in vascular biology.